Compare
Modular Medical, Inc. vs Sonoma Pharmaceuticals, Inc. vs Flyte Aviation, Inc. vs Nephros Inc
| Latest fiscal year | Modular Medical, Inc. MODD | Sonoma Pharmaceuticals, Inc. SNOA | Flyte Aviation, Inc. VJET | Nephros Inc NEPH |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $19.53M | $819.0K | $18.79M |
| Revenue growth (YoY) | n/a | +36.7% | +95.0% | +32.7% |
| Gross margin | n/a | 38.0% | 92.3% | 61.9% |
| Operating margin | n/a | -12.6% | n/m | 6.1% |
| Net margin | n/a | -16.3% | n/m | 6.4% |
| Net income | -$28.24M | -$3.17M | -$17.18M | $1.19M |
| EPS (Diluted) | -$12.36 | -$1.89 | n/a | $0.11 |
| Operating cash flow | -$23.75M | -$3.93M | -$8.30M | $1.60M |
| Free cash flow | -$27.68M | -$4.12M | -$8.31M | n/a |
| Cash & equivalents | $6.94M | $2.40M | $88.0K | $5.40M |
| Total assets | $14.83M | $13.96M | $15.86M | $13.64M |
| Total liabilities | $1.87M | $10.87M | $9.21M | $3.44M |
| Shareholders' equity | $12.96M | $3.10M | $7.05M | $10.20M |
| Return on year-end equity | -217.9% | -102.6% | -243.6% | 11.7% |
| Shares outstanding | 4.66M | 1.80M | 1.74M | 10.64M |
Revenue, most recent five fiscal years
| Fiscal year | Modular Medical, Inc. | Sonoma Pharmaceuticals, Inc. | Flyte Aviation, Inc. | Nephros Inc |
|---|---|---|---|---|
| Latest | $0 Ended 2018-03-31 | $19.53M Ended 2026-03-31 | $819.0K Ended 2025-12-31 | $18.79M Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2017-03-31 | $14.29M Ended 2025-03-31 | $420.0K Ended 2024-12-31 | $14.16M Ended 2024-12-31 |
| 2 years earlier | n/a | $12.73M Ended 2024-03-31 | $442.0K Ended 2023-12-31 | $14.24M Ended 2023-12-31 |
| 3 years earlier | n/a | $13.27M Ended 2023-03-31 | $14.0K Ended 2022-12-31 | $9.97M Ended 2022-12-31 |
| 4 years earlier | n/a | $12.63M Ended 2022-03-31 | $22.0K Ended 2021-12-31 | $10.22M Ended 2021-12-31 |